Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab maintenance therapy for fistulizing Crohn's disease.
Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Sands BE, et al. Among authors: chey wy. N Engl J Med. 2004 Feb 26;350(9):876-85. doi: 10.1056/NEJMoa030815. N Engl J Med. 2004. PMID: 14985485 Free article. Clinical Trial.
A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease.
Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY, Farraye FA, Shafran I, Katz S, Krone CL, Vander Vliet M, Stevens C, Sherman ML, Jacobson E, Bleday R. Burakoff R, et al. Among authors: chey wy. Inflamm Bowel Dis. 2006 Jul;12(7):558-65. doi: 10.1097/01.ibd.0000225337.14356.31. Inflamm Bowel Dis. 2006. PMID: 16804392 Clinical Trial.
Infliximab for refractory ulcerative colitis.
Chey WY, Hussain A, Ryan C, Potter GD, Shah A. Chey WY, et al. Am J Gastroenterol. 2001 Aug;96(8):2373-81. doi: 10.1111/j.1572-0241.2001.04039.x. Am J Gastroenterol. 2001. PMID: 11513177
Infliximab for ulcerative colitis.
Chey WY, Shah A. Chey WY, et al. J Clin Gastroenterol. 2005 Nov-Dec;39(10):920; author reply 920. doi: 10.1097/01.mcg.0000180804.49328.69. J Clin Gastroenterol. 2005. PMID: 16208122 No abstract available.
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease.
Yacyshyn BR, Chey WY, Goff J, Salzberg B, Baerg R, Buchman AL, Tami J, Yu R, Gibiansky E, Shanahan WR; ISIS 2302-CS9 Investigators. Yacyshyn BR, et al. Among authors: chey wy. Gut. 2002 Jul;51(1):30-6. doi: 10.1136/gut.51.1.30. Gut. 2002. PMID: 12077088 Free PMC article. Clinical Trial.
243 results